Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors

NCT03091842 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT03091842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03091842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors
Lead sponsor
University of Southern California
Phase
Not applicable
Overall status
Withdrawn
Start date
July 29, 2019
Completion date
July 29, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer survivor, central obesity, estrogen receptor positive, postmenopausal, progesterone receptor positive, stage i breast cancer, stage ia breast cancer, stage ib breast cancer, stage ii breast cancer, stage iia breast cancer, stage iib breast cancer, stage iii breast cancer, stage iiia breast cancer, stage iiib breast cancer, stage iiic breast cancer